CorMedix Inc (CRMD)

08:25 AM

Will CorMedix Inc. stock benefit from green energy trendsOil Prices & High Return Trade Opportunity Guides - newser.com

08:25 AM

04:23 AM

Will CorMedix Inc. stock recover faster than marketJuly 2025 Reactions & Momentum Based Trading Ideas - newser.com

04:23 AM

02:33 AM

Price action breakdown for CorMedix Inc.Weekly Stock Analysis & Safe Capital Investment Plans - newser.com

02:33 AM

02:04 AM

Is it time to cut losses on CorMedix Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com

02:04 AM

01:29 AM

Will CorMedix Inc. stock outperform Nasdaq index2025 Technical Patterns & Long-Term Growth Portfolio Plans - newser.com

01:29 AM

01:09 AM

Risk adjusted return profile for CorMedix Inc. analyzedBond Market & Fast Entry Momentum Trade Alerts - newser.com

01:09 AM

Oct 12, 2025

What analysts say about CorMedix Inc stockDividend Aristocrats List & Small Budget Trading Portfolio - earlytimes.in

Oct 12, 2025

Oct 10, 2025

Is CorMedix Inc. stock reversal real or fakeWeekly Market Report & Capital Efficiency Focused Ideas - newser.com

Oct 10, 2025

Oct 10, 2025

Backtesting results for CorMedix Inc. trading strategiesJuly 2025 Drop Watch & Accurate Intraday Trading Signals - newser.com

Oct 10, 2025

Oct 09, 2025

CorMedix: Challenging Long-Term Risk-Reward, Maintain Sell - Seeking Alpha

Oct 09, 2025

Oct 09, 2025

Analyzing recovery setups for CorMedix Inc. investorsEntry Point & Fast Moving Market Watchlists - newser.com

Oct 09, 2025

Oct 09, 2025

Is CorMedix Inc. a candidate for recovery play2025 Historical Comparison & Consistent Growth Stock Picks - newser.com

Oct 09, 2025

Oct 07, 2025

Will CorMedix's DefenCath Edge Last If Bigger Heparin Rivals Close In? - sharewise.com

Oct 07, 2025

Oct 06, 2025

How cyclical is CorMedix Inc. (19KA) stock compared to rivalsJobs Report & Verified Swing Trading Watchlist - newser.com

Oct 06, 2025

Oct 06, 2025

Why CorMedix Inc. stock is in analyst buy zone2025 Institutional Moves & Consistent Profit Trade Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

CorMedix (CRMD): Assessing Valuation Following Phase III REZZAYO Trial Enrollment and Melinta Growth Moves - Sahm

Oct 05, 2025

Oct 05, 2025

Is a relief rally coming for CorMedix Inc. holders2025 Earnings Impact & Accurate Intraday Trading Signals - newser.com

Oct 05, 2025

Oct 05, 2025

Will CorMedix Inc. (19KA) stock benefit from Fed rate cutsJuly 2025 Final Week & Risk Managed Investment Signals - newser.com

Oct 05, 2025

Oct 03, 2025

ANGO Stock Gains Following Q1 Earnings Beat, Gross Margin Improves - The Globe and Mail

Oct 03, 2025

Oct 03, 2025

CorMedix (CRMD): Assessing Valuation After Recent Volatility and Analyst Price Targets - Yahoo Finance

Oct 03, 2025

Oct 03, 2025

What macro factors could drive CorMedix Inc. (19KA) stock higherJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com

Oct 03, 2025

Oct 02, 2025

Is it too late to sell CorMedix Inc.Trade Signal Summary & Expert Verified Stock Movement Alerts - newser.com

Oct 02, 2025

Oct 02, 2025

Real time scanner hits for CorMedix Inc. explainedCEO Change & Free Community Consensus Stock Picks - newser.com

Oct 02, 2025

Oct 01, 2025

Is CorMedix Inc. building a consolidation baseDividend Hike & Smart Allocation Stock Reports - newser.com

Oct 01, 2025

Sep 30, 2025

CorMedix files to sell 6.32M shares of common stock for holders - MSN

Sep 30, 2025

Sep 30, 2025

CorMedix Bets Big On Melinta In $300 Million Deal - Finimize

Sep 30, 2025

Sep 30, 2025

CorMedix completes enrollment in phase III fungal infection study By Investing.com - Investing.com Nigeria

Sep 30, 2025

Sep 29, 2025

Cormedix announces completion of enrollment in phase III Respect clinical trial for Rezzayo - MarketScreener

Sep 29, 2025

Sep 29, 2025

CorMedix completes enrollment in phase III fungal infection study - Investing.com

Sep 29, 2025

Sep 29, 2025

Cormedix Announces Completion Of Enrollment In Phase Iii Respect Clinical Trial For Rezzayo - TradingView

Sep 29, 2025

Sep 29, 2025

CorMedix Inc. Completes Enrollment in Phase III ReSPECT Study for REZZAYO® in Fungal Infection Prophylaxis, Topline Results Expected 2Q 2026 - Quiver Quantitative

Sep 29, 2025

Sep 29, 2025

CorMedix Announces Completion of Enrollment in Phase III ReSPECT Clinical Trial for REZZAYO - Yahoo Finance

Sep 29, 2025